STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NEO NEOGENOMICS INCORPORATED StockScouter® Report

4

StockScouter® Score

NEOGENOMICS INCORPORATED, a small cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Two or more executives, directors or major shareholders – including one high-level executive -- purchased a large number of shares recently. Very positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

D
A
C
F

Previous Ratings

5
5
4